Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.44 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.44 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.44 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.44 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5270426 | 1.00 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5271614 | 1.00 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5272182 | 1.00 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5269201 | 1.00 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5269764 | 1.00 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL6868166 | 0.98 | BID (0.41) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL6222946 | 0.93 | TYR (0.39) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL9359701 | 0.85 | CNR1 (0.35) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL9756310 | 0.81 | CA2 (0.33) | — | |
| SCHEMBL21523337 | 0.80 | LIPG (0.49) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023182327-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, ORGANIC EL DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT | 東レ株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-115698854-A | Photosensitive resin composition, cured product, display device, semiconductor device, and method for producing cured product | 东丽株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-104235186-B | Joint bearing lubricant system | 波音公司 | 2019-05-31 | — | — | CN | disclosed |
| CN-104235186-A | Joint bearing lubricant system | BOEING CO | 2014-12-24 | — | — | CN | disclosed |
| EP-1625193-B1 | BORATE ESTER LUBRICANT ADDITIVES | BASF SE (DE) | 2010-07-28 | — | — | EP | disclosed |
| CN-100350025-C | Borate ester lubricant additive | CIBA SC HOLDING AG (CH) | 2007-11-21 | — | — | CN | disclosed |
| US-7291581-B2 | Borate ester lubricant additives | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-11-06 | — | — | US | disclosed |
| EP-1243609-B1 | SUCCINIMIDE COMPOUNDS AND USE THEREOF | IDEMITSU KOSAN CO (JP) | 2007-10-24 | — | — | EP | disclosed |
| CN-1791664-A | Borate ester lubricant additives | CIBA SC HOLDING AG (CH) | 2006-06-21 | — | — | CN | disclosed |
| US-6906191-B2 | Succinimide compounds and use thereof | IDEMITSU KOSAN CO., LTD. (JP) | 2005-06-14 | — | — | US | disclosed |
| US-20040235681-A1 | Borate ester lubricant additives | CIBA SPECIALTY CHEMICALS CORP. | 2004-11-25 | — | — | US | disclosed |
| US-20030018198-A1 | Succinimide compounds and use thereof | IDEMITSU KOSAN CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1243609-A1 | SUCCINIMIDE COMPOUNDS AND USE THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2002-09-25 | — | — | EP | disclosed |
| EP-0457730-B1 | Process for preparation of thioderivatives of alkylhydroxyanilinotriazine | CIBA GEIGY AG (CH) | 1994-11-09 | — | — | EP | disclosed |
| US-5086173-A | Hydrogenating in presence of palladium catalyst without isolating the intermediates | CIBA-GEIGY CORPORATION (US) | 1992-02-04 | — | — | US | disclosed |
| EP-0457730-A2 | Process for preparation of thioderivatives of alkylhydroxyanilinotriazine | CIBA-GEIGY AG (CH) | 1991-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018198-A1 | Succinimide compounds and use thereof | SRM, SMS, SGMS2 | BID 1066/4885MCL1 4450/4885BCL2L1 2199/4885 |
| US-20040235681-A1 | Borate ester lubricant additives | GRK1, BRSK1, EBPL | BID 2154/4885MCL1 3033/4885BCL2L1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.